Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Toronto (Nov. 8, 2005) - A new laboratory facility opened today in Shanghai by the Premier of Ontario Dalton McGuinty and University Health Network Vice President, Research, Dr. Christopher Paige will accelerate an international research program aimed at developing drugs for diseases such as cancer and cardiovascular and immune disorders.
The new laboratory, officially named the Shanghai-Toronto Institute for Health Research, is a joint initiative of University Health Network and the Institute for Health Science, part of the Chinese Academy of Sciences. The institute is located on the campus of the Institute for Health Science and the Shanghai Jiao Tong University School of Medicine. It features a state-of-the-art laboratory for identifying disease biomarkers as well as chemistry laboratories for analyzing potential new drugs.
The institute's Toronto counterpart, a new laboratory in the Toronto Medical Discovery Tower, will open in the coming months. In addition to accelerating cancer research and offering the promise of new cancer drugs, the joint program is expected to support a training exchange program for scientists and physicians and a commercialization portfolio for intellectual property. Premier McGuinty presided at the ribbon-cutting in Shanghai as part of the Ontario Trade and Investment Mission to China, a mission focusing on innovation and strengthening ties with the Asian powerhouse.
UHN Research (www.uhnresearch.ca) is a leading-edge biomedical and healthcare research organization with international stature, and is a teaching partner of the University of Toronto. Our research institutes (Ontario Cancer Institute, Toronto General Research Institute and Toronto Western Research Institute) are home to 465 scientists and clinician scientists, and more than 1900 staff and trainees. In 2004/2005 UHN Research had a research budget of $161M. Our researchers lead programs in cancer, cardiology, transplantation, immunology and autoimmunity, infectious diseases, tissue injury, diabetes, neural and visual sciences, musculoskeletal disease, and urban and community health. UHN Research brings together the innovation, talent and resources to achieve global impact in basic, translational and clinical research.
Phone: 416 340 4636